New hope for advanced prostate cancer: drug combo trial launches
NCT ID NCT06401980
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study tests whether adding darolutamide to standard treatments can help men with a certain type of advanced prostate cancer (mCRPC) live longer without their cancer getting worse. About 162 participants will receive either standard care alone or standard care plus darolutamide. The goal is to see if the combination improves outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire Vaudois CHUV
RECRUITINGLausanne, CH-1011, Switzerland
-
Hôpitaux Universitaires Genève HUG
RECRUITINGGeneva, 1211, Switzerland
-
Inselspital
RECRUITINGBern, Switzerland
-
Istituto Oncologico della Svizzera Italiana (IOSI)
RECRUITINGBellinzona, 6500, Switzerland
-
Kantonsspital Baden
RECRUITINGBaden, 5404, Switzerland
-
Kantonsspital Graubuenden
RECRUITINGChur, 7000, Switzerland
-
Kantonsspital St. Gallen
RECRUITINGSankt Gallen, Switzerland
-
Kantonsspital Winterthur
RECRUITINGWinterthur, 8401, Switzerland
-
Luzerner Kantonsspital
RECRUITINGLucerne, 6004, Switzerland
-
OnkoZentrum Zürich - Standort Seefeld
TERMINATEDZurich, 8038, Switzerland
-
Stadtspital Triemli Zürich
RECRUITINGZurich, 8063, Switzerland
-
Tumorzentrum Aarau TZA
RECRUITINGAarau, 5000, Switzerland
-
UniversitaetsSpital Zuerich
RECRUITINGZurich, 8091, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Chemo combo vs. radioactive drug: which tames aggressive prostate cancer?
- Can a new pill outsmart resistant prostate cancer?
- Can a radioactive 'Smart Bomb' outsmart advanced prostate cancer?
- Can an immune booster make hormone therapy work better against prostate cancer?
- Can a pill outsmart Tumors' defenses?
- Can targeted radiation tame advanced prostate cancer? a registry aims to find out